Evidence map›Paper›PMID 39820169›Full record

ArticlePLoS genetics2025

Investigative genetic genealogy practices warranting policy attention: Results of a modified policy Delphi.

Christi J Guerrini, Louiza Kalokairinou, Jill O Robinson, Whitney Bash Brooks, Stephanie M Fullerton, Sara Huston, Jacklyn Dahlquist, Diana Madden, Norah Crossnohere, Nicola Campoamor and 2 more

Abstract read
In one paragraph

Article in PLoS genetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Christi J GuerriniCenter for Medical Ethics and Health Policy, Baylor College of Medicine, Houston, Texas, United States of America.ORCID https://orcid.org/0000-0003-4430-2740
Louiza KalokairinouCenter for Medical Ethics and Health Policy, Baylor College of Medicine, Houston, Texas, United States of America.
Jill O RobinsonCenter for Medical Ethics and Health Policy, Baylor College of Medicine, Houston, Texas, United States of America.
Whitney Bash BrooksCenter for Medical Ethics and Health Policy, Baylor College of Medicine, Houston, Texas, United States of America.
Stephanie M FullertonDepartment of Bioethics and Humanities, University of Washington School of Medicine, Seattle, Washington, United States of America.ORCID https://orcid.org/0000-0002-0938-6048
Sara HustonMary Ann & J. Milburn Smith Child Health Outcomes, Research, and Evaluation Center, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States of America.ORCID https://orcid.org/0000-0002-5044-8765
Jacklyn DahlquistDepartment of Bioethics and Humanities, University of Washington School of Medicine, Seattle, Washington, United States of America.
Diana MaddenMary Ann & J. Milburn Smith Child Health Outcomes, Research, and Evaluation Center, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States of America.
Norah CrossnohereDepartment of Internal Medicine, College of Medicine, The Ohio State University Wexner Medical Center.
Nicola CampoamorDepartment of Biomedical Informatics, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, Ohio, United States of America.ORCID https://orcid.org/0009-0005-7836-5135
John F P BridgesDepartment of Biomedical Informatics, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, Ohio, United States of America.
Amy L McGuireCenter for Medical Ethics and Health Policy, Baylor College of Medicine, Houston, Texas, United States of America.

Funding

IGG on the Internet: Characterizing Public Perspectives on Law Enforcement Use of Genetic Genealogy Data in Social MediaR01HG011268 · NHGRI · BAYLOR COLLEGE OF MEDICINE · PI GUERRINI, CHRISTI, MCGUIRE, AMY L · 2020 to 2023
$2.4M
NHGRI NIH HHS R01 HG011268
6 · The paper itself

Abstract

A technique known as investigative genetic genealogy (IGG) was first introduced to criminal investigations in 2018, and it has since been used by U.S. law enforcement to help identify hundreds of criminal perpetrators and unidentified human remains. As expertise in IGG grows, policymakers have shown interest in regulating it. To help inform these efforts and to promote coherence in IGG governance as it expands, we recruited experts representing a spectrum of IGG-relevant professions and perspectives to identify and prioritize IGG practices for policy attention and to develop policy options for addressing them. In two rounds of a modified policy Delphi, 31 participants prioritized nine IGG practices for policy attention. These top priority practices relate to: consent and notification; case eligibility and criteria; data management, privacy, and security; and governance and accountability. Participants expressed a range of opinions, some strongly held, and did not reach complete consensus with respect to any of the practices. However, convergence was strongest with respect to law enforcement participation in direct-to-consumer genetic genealogy databases against terms of service, which a large majority opposed and almost half evaluated as top priority for policy attention. Participants also voiced strong and consistent concern about management of data and samples collected and generated during IGG and the governance of private laboratories involved in IGG. Our study demonstrates the feasibility and value of engaging with diverse experts over an extended period on a pressing matter of public policy and provides a needed empirical foundation for IGG policymaking.

Indexed as

Forensic GeneticsGenealogy and HeraldryDelphi TechniqueGenetic PrivacyHumansPedigreeUnited States

Identifiers

PMID39820169
PMCPMC11737847

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.